INTERLEUKIN-7, INTERLEUKIN-8, SOLUBLE TNF RECEPTOR, AND P53 PROTEIN-LEVELS ARE ELEVATED IN THE SERUM OF PATIENTS WITH HODGKINS-DISEASE

被引:50
作者
TRUMPER, L
JUNG, W
DAHL, G
DIEHL, V
GAUSE, A
PFEUNDSCHUH, M
机构
[1] UNIV SAARLAND,MED KLIN & POLIKLIN,D-66421 HOMBURG,GERMANY
[2] UNIV COLOGNE,MED KLIN 1,W-5000 COLOGNE 41,GERMANY
关键词
CYTOKINES; HODGKINS LYMPHOMA; IL-4; IL-7; IL-8; PROGNOSTIC FACTORS; TNF RECEPTOR; P53;
D O I
10.1093/annonc/5.suppl_1.S93
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In a search for specific serum markers with prognostic impact, we evaluated the clinical significance of IL-4, IL-7, and IL-8 as well as TNF receptor levels and soluble p53 in the serum of patients with untreated Hodgkin's lymphoma (HD). No elevations were observed for IL-4, while IL-7 and IL-8 were elevated in 15/52 (29%) and 21/78 (27%) patients, respectively. Soluble TNF receptors were detected in 16/29 patients (55%), and were significantly elevated in 6 (21%). P53 was detected in 21/33 (64%) patients. While IL-7 levels, detectable sTNF receptors, and p53 were not correlated with other obvious parameters, elevated IL-8 levels were associated with the presence of B symptoms (p < 0.002) and occurred more often in the nodular sclerosis form than in other histological subtypes (p < 0.02). Further investigations that correlate these serum parameters with the situation at the cellular level of an involved tissue will help to elucidate the enigmatic biology of HD.
引用
收藏
页码:S93 / S96
页数:4
相关论文
共 21 条
[1]   MOLECULAR-CLONING AND EXPRESSION OF A NEW MEMBER OF THE NERVE GROWTH-FACTOR RECEPTOR FAMILY THAT IS CHARACTERISTIC FOR HODGKINS-DISEASE [J].
DURKOP, H ;
LATZA, U ;
HUMMEL, M ;
EITELBACH, F ;
SEED, B ;
STEIN, H .
CELL, 1992, 68 (03) :421-427
[2]   EVOLUTION OF ERYTHROCYTE SEDIMENTATION-RATE AS PREDICTOR OF EARLY RELAPSE IN POSTTHERAPY EARLY-STAGE HODGKINS-DISEASE [J].
FRIEDMAN, S ;
HENRYAMAR, M ;
COSSET, JM ;
CARDE, P ;
HAYAT, M ;
DUPOUY, N ;
TUBIANA, M .
JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (04) :596-602
[3]  
GAUSE A, 1991, BLOOD, V77, P1983
[4]   LOW SERUM INTERLEUKIN-2 RECEPTOR LEVELS CORRELATE WITH A GOOD PROGNOSIS IN PATIENTS WITH HODGKINS LYMPHOMA [J].
GAUSE, A ;
ROSCHANSKY, V ;
TSCHIERSCH, A ;
SMITH, K ;
HASENCLEVER, D ;
SCHMITS, R ;
DIEHL, V ;
PFREUNDSCHUH, M .
ANNALS OF ONCOLOGY, 1991, 2 :43-47
[5]  
GAUSE A, 1992, HAEMATOL ONCOL, V9, P307
[6]  
GAUSE A, 1991, LYMPHOKINE CYTOK RES, V11, P109
[7]  
Gruss H.-J., 1992, Annals of Hematology, V65, pA62
[8]  
GRUSS HJ, 1991, 2ND INT S HODGK DIS, P12
[9]   P53 EXPRESSION IN REED-STERNBERG CELLS OF HODGKINS-DISEASE [J].
GUPTA, RK ;
NORTON, AJ ;
THOMPSON, IW ;
LISTER, TA ;
BODMER, JG .
BRITISH JOURNAL OF CANCER, 1992, 66 (04) :649-652
[10]   MOLECULAR-CLONING AND EXPRESSION OF HUMAN AND RAT-TUMOR NECROSIS FACTOR RECEPTOR CHAIN (P60) AND ITS SOLUBLE DERIVATIVE, TUMOR NECROSIS FACTOR-BINDING PROTEIN [J].
HIMMLER, A ;
MAURERFOGY, I ;
KRONKE, M ;
SCHEURICH, P ;
PFIZENMAIER, K ;
LANTZ, M ;
OLSSON, I ;
HAUPTMANN, R ;
STRATOWA, C ;
ADOLF, GR .
DNA AND CELL BIOLOGY, 1990, 9 (10) :705-715